Background/Objectives: Spinoplastic surgery is an emerging multidisciplinary field developed to address and reduce the complication of pseudoarthrosis following complex spinal reconstructions. While the number of spinal fusion procedures continues to rise every year, fusion failure rates remain as high as 40%. Although pseudoarthrosis may not always manifest clinically, it remains a leading cause of persistent pain and need for subsequent revision surgeries. The multidisciplinary collaboration between spine and plastic surgeons in spinoplastic surgery has therefore emerged as a proactive strategy aimed at preventing complications, particularly in patients identified as high-risk for pseudoarthrosis. As the patient population expands and spinoplastic surgery continues to evolve, refining patient selection criteria becomes essential for achieving optimal surgical outcomes. This review aims to provide a comprehensive overview of recent advancements in spinoplastic surgery, highlighting current indications, surgical techniques, recent case reports, and strategies for identifying suitable candidates. Methods: We performed a narrative review of English language literature through April 2025. Spinoplastic case reports and case series published within the last 20 years were included in the review. Results: Indications for use of a spinoplastic approach clustered into prior fusion failure, extensive oncologic resection, severe spinal deformity, procedures requiring extensive spinal involvement, and/or patients at risk for impaired bone healing. Succesful radiographic union and improvement of symptoms were widely reported across all 9 case reports/series. Conclusions: Although evidence is presently limited, spinoplastic surgery appears to achieve high bone graft fusion rates with acceptable morbidity and functional improvement in a carefully selected group of high-risk spinal reconstruction patients. Still, larger prospective studies are warranted to refine patient selection and validate functional benefit.

Unilateral yellow discoloration of the eye, commonly referred to as scleral icterus, is an uncommon clinical finding; there are only 14 cases of persistent unilateral scleral icterus documented in the literature. Here, the authors describe a patient with Gilbert’s syndrome who presented with left-sided conjunctival and scleral icterus presumed secondary to poor vascular outflow following surgical and radiation treatment of squamous cell carcinoma of the left ear with parotid and cervical lymph node involvement. The current case describes a unique physical finding, reviews the pathophysiology of conjunctival and scleral icterus, and reviews the current literature on this topic.

To present a rare case of a suspected ophthalmic artery fat embolus in a patient who underwent bilateral elbow liposuction. The patient, a 44-year-old female with past smoking history and stable meningioma with no associated symptoms, presented with episodes of transient vision loss followed by a persistent “arc-like” scotoma in her left eye one month after bilateral elbow liposuction. Ophthalmic examination and imaging of the left eye revealed a visual acuity of 20/25, a paracentral scotoma, delayed perfusion, and decreased retinal thickness. A head and neck computerized tomography angiogram with intravenous contrast and diagnostic cerebral angiogram identified occlusion of the left ophthalmic artery. Following this, she received intra-arterial tissue plasminogen activator, after which her vision subjectively deteriorated, accompanied by an enlargement of the paracentral scotoma, the development of a new relative afferent pupillary defect, and additional areas of retinal ischemia. Coagulation studies, autoimmune studies, and echocardiogram imaging showed no remarkable findings, thereby decreasing the likelihood of other vascular or embolic etiologies. At her most recent follow-up visit, five months post-presentation, she reported no worsening of her symptoms or scotoma. Examination and imaging demonstrated stabilization of her ocular findings. This case highlights the potential risk of ocular complications following non-facial cosmetic procedures, emphasizing the need for ophthalmologists to carefully review patients' cosmetic surgery histories when assessing unexplained visual symptoms.